Production (Stage)
Galera Therapeutics, Inc.
GRTX
$0.0326
$0.005118.55%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.59M | -4.93M | -5.58M | -4.06M | -4.38M |
| Total Depreciation and Amortization | -- | 0.00 | 5.00K | 6.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -157.00K | 3.79M | 3.54M | 723.00K | 875.00K |
| Change in Net Operating Assets | -489.00K | -1.20M | -257.00K | 618.00K | -1.29M |
| Cash from Operations | -2.24M | -2.34M | -2.30M | -2.72M | -4.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 4.00K | -- | -- |
| Cash Acquisitions | -- | -50.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -50.00K | 4.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 635.00K | 2.22M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 635.00K | 2.22M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.60M | -166.00K | -2.29M | -2.72M | -4.79M |